CancerWorld shared a post on X:
“Michel Goldman: A Teacher Until the End
At 70, Michel Goldman has lived many lives — world-renowned immunologist, founding president of I3h, and former executive director of Europe’s €2B Innovative Medicines Initiative.
But his story goes beyond titles. Goldman is also a lymphoma patient, a scientist whose decades studying lymphocytes became a mirror for his own illness.
- He reshaped Europe’s approach to research, founding the European Patients’ Academy on Therapeutic Innovation (EUPATI) to put patients at the heart of drug development.
- As Editor-in-Chief of Frontiers in Medicine, he continues to champion ethics, integrity, and science made understandable to all.
- Even after diagnosis, he kept teaching — as editor-in-chief of Frontiers in Medicine, championing ethics, integrity, and science made understandable to all.
“If students leave my class understanding how science connects to people’s lives, I’ve done my job.”
Read the full article to learn more about Michel Goldman’s story and the person behind all these titles.”
More posts featuring CancerWorld.